Table of Contents

company-logo

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

AVROBIO Dividend Announcement

• AVROBIO does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on AVROBIO dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AVROBIO Dividend History

AVROBIO Dividend Yield

AVROBIO current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AVROBIO stock? Use our calculator to estimate your expected dividend yield:

AVROBIO Financial Ratios

P/E ratio2.07
PEG ratio-0.02
P/B ratio0.71
ROE29.68%
Payout ratio0.00%
Current ratio26.17
Quick ratio26.17
Cash Ratio25.87

AVROBIO Dividend FAQ

Does AVROBIO stock pay dividends?
AVROBIO does not currently pay dividends to its shareholders.
Has AVROBIO ever paid a dividend?
No, AVROBIO has no a history of paying dividends to its shareholders. AVROBIO is not known for its dividend payments.
Why doesn't AVROBIO pay dividends?
There are several potential reasons why AVROBIO would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AVROBIO ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AVROBIO has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AVROBIO a dividend aristocrat?
AVROBIO is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AVROBIO a dividend king?
AVROBIO is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AVROBIO a dividend stock?
No, AVROBIO is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AVROBIO stocks?
To buy AVROBIO you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AVROBIO stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.